Image source: BlazeTV screenshot
© 2024 Blaze Media LLC. All rights reserved.
TRADE WAR: With most pharmaceutical drugs being imported from China, should the US be concerned about China's ambitions?
September 17, 2019
On Tuesday's episode of "Pat Gray Unleashed," Pat and Keith discussed why some U.S. national security officials are concerned about potential interruptions in the supply of pharmaceutical antibiotics imported from China.
In her book, "China Rx," author Rosemary Gibson wrote, "Antibiotics are considered the single most significant advancement in modern medicine. The vast majority of key ingredients used to make prescription drugs that Americans depend on are manufactured mostly in China."
"They have got us by the throat," Pat said.
"If China shut the door on exports of medicines and their key ingredients and raw material, U.S. hospitals and military hospitals and clinics would cease to function within months, if not days," Gibson said.
According to an NBC News translation, a leading Chinese economist said, "China is the world's largest exporter of vitamins and antibiotic raw materials. Once the export is reduced, the medical systems of some developed countries will not work."
Gibson went on to explain how the last penicillin plant in the U.S. closed in 2004, which meant the U.S. is reliant on China for the the lifesaving drug.
"This is terrifying," Pat said. Keith agreed.
Watch the video below for more.
Download the podcast here.
Use code PAT to save $10 on one year of BlazeTV.
Want more from Pat Gray?
To enjoy more of Pat's biting analysis and signature wit as he restores common sense to a senseless world, subscribe to BlazeTV — the largest multi-platform network of voices who love America, defend the Constitution and live the American dream.
Want to leave a tip?
We answer to you. Help keep our content free of advertisers and big tech censorship by leaving a tip today.
Want to join the conversation?
Already a subscriber?
News, opinion, and entertainment for people who love the American way of life.
BlazeTV
more stories
Sign up for the Blaze newsletter
By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.
© 2024 Blaze Media LLC. All rights reserved.
Get the stories that matter most delivered directly to your inbox.
By signing up, you agree to our Privacy Policy and Terms of Use, and agree to receive content that may sometimes include advertisements. You may opt out at any time.